Use of anticholinergics and the risk of cognitive impairment in an African American population.

Neurology
N L CampbellK Hall

Abstract

Anticholinergic properties of certain medications often go unrecognized, and are frequently used by the elderly population. Few studies have yet defined the long-term impact of these medications on the incidence of cognitive impairment. We report a 6-year longitudinal, observational study, evaluating 1,652 community-dwelling African American subjects over the age of 70 years who were enrolled in the Indianapolis-Ibadan Dementia Project between 2001 and 2007 and who had normal cognitive function at baseline. The exposure group included those who reported the baseline use of possible or definite anticholinergics as determined by the Anticholinergic Cognitive Burden scale. Our main outcome measure was the incidence of cognitive impairment, defined as either dementia or cognitive impairment not dementia, or poor performance on a dementia screening instrument during the follow-up period. At baseline, 53% of the population used a possible anticholinergic, and 11% used a definite anticholinergic. After adjusting for age, gender, educational level, and baseline cognitive performance, the number of definite anticholinergics was associated with an increased risk of cognitive impairment (odds ratio [OR] 1.46, 95% confidence interval [CI] ...Continue Reading

References

Jan 1, 1991·Advances in Experimental Medicine and Biology·H C FibigerJ C Day
Jan 1, 1988·Neuropsychologia·P BroksS M Stahl
Jan 1, 1986·Behavioral and Neural Biology·T G Aigner, M Mishkin
Sep 18, 1993·Lancet·J PoirierS Gauthier
Jan 1, 1993·Neuroreport·E K Miller, R Desimone
Sep 4, 1999·Dementia and Geriatric Cognitive Disorders·L E Tune, S Egeli
May 25, 2002·Journal of the American Geriatrics Society·Joseph T HanlonJudith Garrard
Nov 5, 2003·Journal of Neuroscience Research·Tobias M J AllinsonNigel M Hooper
Jul 31, 2007·Journal of the American Geriatrics Society·Malaz BoustaniHugh Hendrie
Dec 20, 2008·Journal of the American Geriatrics Society·Ling HanHeather G Allore
Jun 12, 2009·Journal of the American Geriatrics Society·Richard L NahinUNKNOWN Ginkgo Evaluation of Memory Study Investigators
Jan 1, 2006·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Hugh C HendrieMolly V Wagster
Jul 29, 2009·Archives of Internal Medicine·Isabelle CarrièreMarie-Laure Ancelin

❮ Previous
Next ❯

Citations

Nov 1, 1990·Immunology Today·J A HabeshawF Manca
Sep 20, 2011·Age and Ageing·Chris FoxCornelius Katona
Jun 10, 2011·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Sarah N HilmerDarrell R Abernethy
Dec 14, 2012·Respiration; International Review of Thoracic Diseases·Babar A Khan
Feb 5, 2014·Journal of Psychiatric Research·Dominique L MusselmanPhilip D Harvey
Aug 23, 2012·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Sahar KarimiPatricia W Slattum
Oct 21, 2010·European Archives of Psychiatry and Clinical Neuroscience·Frank JessenWolfgang Maier
Oct 29, 2014·Canadian Journal of Physiology and Pharmacology·Shamsherjit KaurAtish Prakash
Jan 16, 2014·International Review of Psychiatry·Juanita HoeGill Livingston
Jun 4, 2011·Expert Opinion on Drug Safety·Philip Gerretsen, Bruce G Pollock
Oct 13, 2015·Current Medical Research and Opinion·Patricia E McLarinRonald L Castelino
May 2, 2015·Aging Clinical and Experimental Research·Agnese CollamatiFrancesco Landi
Oct 8, 2013·Clinics in Geriatric Medicine·Noll L CampbellMalaz A Boustani
Sep 14, 2013·Journal of the American Pharmacists Association : JAPhA·Teri WestRuth Emptage
Nov 28, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Xueya CaiMalaz Boustani
Aug 23, 2011·Journal of the American Medical Directors Association·John E Morley
Sep 10, 2015·European Journal of Clinical Pharmacology·Tanja MayerHanna M Seidling
Jan 17, 2013·Journal of the American Geriatrics Society·Alain KoyamaKristine Yaffe
Dec 7, 2011·Journal of the American Geriatrics Society·Noll CampbellMalaz Boustani
Jan 15, 2014·Journal of the American Geriatrics Society·Mandavi KashyapCara Tannenbaum
Jan 20, 2015·Journal of the American Geriatrics Society·Mohammed Saji SalahudeenPrasad S Nishtala
Jun 9, 2016·Critical Care Medicine·Babar A KhanMalaz A Boustani
Oct 4, 2016·Therapeutic Advances in Drug Safety·Shelly L Gray, Joseph T Hanlon
Oct 22, 2016·American Journal of Alzheimer's Disease and Other Dementias·Vishal BaliRajender R Aparasu
Jan 3, 2018·Geriatrics & Gerontology International·Fabrizia LattanzioAndrea Corsonello
May 22, 2018·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Leah H RubinJeffrey R Bishop
Jan 22, 2019·Journal of the American Geriatrics Society·Noll L CampbellMalaz A Boustani
Dec 28, 2018·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Lana SargentLuigi Ferrucci
Feb 7, 2018·Drugs & Aging·Ariel R GreenElizabeth A Bayliss

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.